Related Experiment Video

Updated: Jan 6, 2026

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
03:35

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

Published on: December 1, 2023

571

[Influence of nutritional status on clinical outcomes in hospitalised children]

Jimena Pérez Moreno1, Sara de la Mata Navazo2, Estíbaliz López-Herce Arteta2

  • 1Sección de Hospitalización de Pediatría, Hospital General Universitario Gregorio Marañón, Madrid, España; Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, España.

Anales De Pediatria
|October 9, 2019
PubMed

Insights

Nearly 50% of hospitalized children face high malnutrition risk. This risk, identified by the Screening Tool for the Assessment of Malnutrition in Paediatrics (STAMP), correlates with longer hospital stays and increased illness severity.

Area of Science:

  • Pediatric Medicine
  • Clinical Nutrition
  • Hospital Epidemiology

Background:

  • Paediatric malnutrition is a common hospital comorbidity, affecting approximately 31.4% of children.
  • Malnutrition during hospital admission can negatively impact clinical outcomes in pediatric patients.

Purpose of the Study:

  • To assess malnutrition risk in hospitalized children using the STAMP tool.
  • To investigate the association between malnutrition risk and clinical outcomes, including illness severity and length of stay.

Main Methods:

  • A prospective, analytical study involving 200 children aged 1 month to 15 years admitted to a tertiary hospital.
  • Utilized the validated Screening Tool for the Assessment of Malnutrition in Paediatrics (STAMP) for risk classification.
  • Employed multivariate statistical analysis to identify predictors of illness severity.

Main Results:

  • Nearly 50% of hospitalized children presented with a high risk of malnutrition (STAMP ≥4) upon admission.
  • A higher STAMP score was significantly associated with a longer hospital stay (P<.01) and increased illness severity (P<.01).
  • Multivariable analysis indicated that STAMP is a predictor of illness severity (OR 1.48, P<.01).

Conclusions:

  • The STAMP screening tool identified a high risk of malnutrition in almost half of the hospitalized pediatric patients.
  • Malnutrition risk at admission, as measured by STAMP, is linked to prolonged hospital stays and greater illness severity.
  • Evaluating malnutrition risk upon admission is crucial for understanding and potentially mitigating illness severity in pediatric patients.
Abstract

Keywords:
Cribado nutricionalDesnutrición hospitalariaEstado nutricionalHospital admissionHospital malnutritionHospitalización pediátricaMalnutriciónMalnutritionNutritional assessmentNutritional screeningNutritional statusValoración nutricional

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K
Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil06:48

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

Published on: July 29, 2020

5.0K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
210
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
311
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
227
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
596
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
163
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.1K